Dr. Marisa A. Kollmeier, MD
- Medicare services, 2024
- 1,697
- Medicare patients, 2024
- 299
- Part D claims, 2024
- 58
- Publications
- 98
- Clinical trials
- 1
- Practice address
- 1275 York Avenue, New York, NY 10065
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Kollmeier's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Marisa A. Kollmeier is a radiation oncologist in New York, New York
Dr. Kollmeier practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.
Dr. Kollmeier's NPI, 1215917612, was assigned on January 20, 2006. Dr. Kollmeier graduated from Tel Aviv University Sackler in 1999. Dr. Kollmeier holds New York license 220156.
- NPI
- 1215917612NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2264494780
- NPI enumeration date
- January 20, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 53
- Medical school graduation
- 1999
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Marisa A. Kollmeier practices at Memorial Sloan Kettering Cancer Center in New York, New York
Dr. Kollmeier's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.
- Memorial Sloan Kettering Cancer Center1275 York Avenue, New York, NY 10065
Source: Dmand AI Affiliation Data
Dr. Marisa A. Kollmeier is affiliated with 1 site of care and 3 medical groups
Dr. Kollmeier's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Kollmeier to 2 more medical groups, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Marisa A. Kollmeier's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kollmeier practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Memorial Sloan Kettering Cancer Center | Available with a free account |
| +2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Marisa A. Kollmeier is one of 385 radiation oncologists in New York
Radiation oncology is Dr. Kollmeier's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Kollmeier is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Kollmeier's licenses on file in 2 states: New York and Florida.
Specialties and state licenses
- Radiation oncology, New YorkPrimary
- Florida license
Clinical focus
Dmand AI lists bladder cancer radiation, bone cancer radiation, cervical cancer radiation, prostate cancer radiation and uterine cancer radiation among the conditions Dr. Kollmeier treats.
Radiation oncologists near Dr. Kollmeier
Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Marisa A. Kollmeier billed Medicare for 1,697 services in 2024
CMS data shows 1,697 Medicare services from Dr. Kollmeier across 19 procedure codes in 2024, for 299 Medicare patients. Medicare paid $182,240 for them.
Dr. Kollmeier's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Imaging
- 2023: 6672024: 1,08362%
- Office and hospital visits
- 2023: 2212024: 24611%
- Other services
- 2023: 4902024: 20059%
- Surgery
- 2023: 942024: 16879%
Where Dr. Kollmeier's Medicare services took place, 2024
- In an office54932%
- In a facility1,14868%
Dr. Kollmeier compared with the New York median for radiation oncologists, 2024
- Dr. Kollmeier
- New York median
- Medicare services
- 1,697vs 1,05461% above
- Medicare patients
- 299vs 16087% above
- Part D claims
- 35vs 36Close to median
Medians across 368 radiation oncologists in New York with Dmand AI profiles that report each measure.
Dr. Kollmeier's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Kollmeier?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kollmeier and other radiation oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Marisa A. Kollmeier treated 299 Medicare patients in 2024, average age 74
CMS counts 299 Medicare patients who saw Dr. Kollmeier in 2024. The largest group is 65 to 74, with 162 patients. 75% of them have cancer, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Kollmeier's median patient age at 72, with 32% women.
Dr. Kollmeier's Medicare patients by age, 2024
Dr. Kollmeier's Medicare patients by sex, 2024
- Women8930%
- Men21070%
Chronic conditions among Dr. Kollmeier's Medicare patients, 2024
- Cancer75%
- High cholesterol75%
- High blood pressure74%
- Arthritis48%
- Ischemic heart disease30%
- Diabetes29%
- Mood disorders26%
- Anxiety25%
Share of Medicare patients with each condition. A patient can have several.
Dr. Kollmeier's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women32%
- Men67%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Marisa A. Kollmeier wrote 58 Medicare Part D claims in 2024
In 2024, Dr. Kollmeier wrote 58 Medicare Part D claims for 24 patients. 91% of them were for generic drugs. CMS names the drug for 35 of them, across 2 drugs with 11 or more claims each, at $343 in total drug cost. In 2023, CMS named 32 claims across 2 drugs.
Dr. Kollmeier's Part D claims by kind of drug, 2024
- Generic53 claims91%
- Brand-name and other5 claims9%
Dr. Kollmeier's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 322024: 359%
Drugs named by CMS: 2 in 2024, 2 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Marisa A. Kollmeier scored 91 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Kollmeier for performance year 2024, reported as part of a group. Dr. Kollmeier accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kollmeier as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Kollmeier's MIPS scores, performance year 2024
- 91of 100Final score
- 93.7of 100Quality
- 40of 100Improvement Activities
- 72of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Marisa A. Kollmeier has 98 publications on record
Dmand AI links 98 papers to Dr. Kollmeier, published from 2007 to 2024. 2020 was the busiest year, with 10. The most frequent topics are Prostatic Neoplasms, Brachytherapy and Prostate-Specific Antigen. Dr. Kollmeier has published most often in Brachytherapy. Dr. Kollmeier's most frequent co-authors are Michael J. Zelefsky, MD, Daniel J. Gorovets, MD and Yoshiya Yamada, MD.
Dr. Kollmeier's papers by year, 2015 to 2024
Topics Dr. Kollmeier writes about most
- Prostatic Neoplasms
- Brachytherapy
- Prostate-Specific Antigen
- Radiotherapy Dosage
- Radiotherapy, Intensity-Modulated
- Prostate
- Radiation Injuries
- Rectum
Dr. Kollmeier's most frequent co-authors
- Michael J. Zelefsky, MD35 shared papers
- Daniel J. Gorovets, MD22 shared papers
- Yoshiya Yamada, MD18 shared papers
Recent publications by Dr. Kollmeier
JAMA Netw Open
See who Dr. Kollmeier researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kollmeier works with, so you can find a warm path to the right radiation oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Marisa A. Kollmeier has worked on 1 clinical trial
Dmand AI links Dr. Kollmeier to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Urinary Bladder Neoplasms and Urinary Bladder Diseases.
Conditions in Dr. Kollmeier's trials
- Urinary Bladder Neoplasms
- Urinary Bladder Diseases
Recent clinical trials with Dr. Kollmeier
Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Marisa A. Kollmeier received $5,058 in industry payments from 2019 to 2025
CMS Open Payments shows 16 general payments to Dr. Kollmeier from 5 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 70% of the total. Siemens Medical Solutions USA, Inc. paid the most, $3,678.
General payments to Dr. Kollmeier by program year, 2019 to 2025
General payments to Dr. Kollmeier by kind, 2019 to 2025
- Consulting fees$3,56070%
- Food and beverage$1,47829%
- Travel and lodging$210%
Companies that paid Dr. Kollmeier the most, 2019 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Marisa A. Kollmeier graduated from Tel Aviv University Sackler
Dr. Kollmeier graduated from Tel Aviv University Sackler in 1999.
- Medical school
- Board certified in radiation oncology
Source: Dmand AI Professional Profile Data
Dr. Marisa A. Kollmeier accepts plans from 9 insurance carriers
Dr. Kollmeier is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.
- Aetna
- Excellus BlueCross BlueShield
- Blue Cross Blue Shield of Michigan
- Blue Cross Blue Shield of Massachusetts
- HCSC
- MVP Health Care
- Regence Health Plans
- CMS Medicare
- +1 more carriersWith a free account
Plan types Dr. Kollmeier accepts, by number of carriers
- Medicare7
- PPO7
- EPO3
- POS3
- HMO2
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Marisa A. Kollmeier's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Marisa A. Kollmeier
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Marisa A. Kollmeier's NPI number?
Dr. Marisa A. Kollmeier's NPI number is 1215917612. It was assigned on January 20, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Marisa A. Kollmeier?
Dr. Marisa A. Kollmeier is a radiation oncologist in New York, New York. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).
Where does Dr. Marisa A. Kollmeier practice?
Dr. Kollmeier practices at 1275 York Avenue, New York, NY 10065. Dr. Kollmeier's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Kollmeier to 2 medical groups.
What is Dr. Marisa A. Kollmeier's medical license number?
Dr. Kollmeier holds New York license 220156, one of the licenses on file in 2 states.
Which states has Dr. Marisa A. Kollmeier been licensed in?
Dmand AI has state licenses on file for Dr. Kollmeier in New York (2001 to 2026) and Florida (since 2023).
Which hospitals is Dr. Marisa A. Kollmeier affiliated with?
Dr. Kollmeier practices at Memorial Sloan Kettering Cancer Center in New York, New York.
What medical group is Dr. Marisa A. Kollmeier part of?
Dr. Kollmeier is linked to Memorial Sloan Kettering Cancer Center. Dmand AI links Dr. Kollmeier to 2 more medical groups.
Does Dr. Marisa A. Kollmeier accept Medicare?
Yes. CMS data shows Dr. Kollmeier billed Medicare for 1,697 services in 2024, and Dr. Kollmeier accepts Medicare assignment.
Does Dr. Marisa A. Kollmeier offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Kollmeier as offering telehealth services.
What is Dr. Marisa A. Kollmeier's MIPS score?
Dr. Kollmeier's MIPS final score for performance year 2024 is 91 out of 100, reported as part of a group.
Show 10 more questionsShow fewer questions
How many Medicare patients does Dr. Marisa A. Kollmeier see?
CMS counts 299 Medicare patients who saw Dr. Kollmeier in 2024, with an average age of 74.
Is Dr. Marisa A. Kollmeier board certified?
Yes. Dr. Kollmeier is board certified in radiation oncology by the American Board of Radiology.
What services does Dr. Marisa A. Kollmeier bill to Medicare?
In 2024, Dr. Kollmeier's most billed Medicare services were radiation oncology (77300), medicare service (G6002) and office visit, established patient (99213).
Where did Dr. Marisa A. Kollmeier go to medical school?
Dr. Kollmeier graduated from Tel Aviv University Sackler in 1999.
What drugs does Dr. Marisa A. Kollmeier prescribe most?
In 2024 Medicare Part D data, Dr. Kollmeier's most prescribed drugs by claims were Tamsulosin HCl and Oxybutynin Chloride ER.
Has Dr. Marisa A. Kollmeier received payments from drug or device companies?
CMS Open Payments shows $5,058 in general payments to Dr. Kollmeier from 5 companies from 2019 to 2025. The largest total came from Siemens Medical Solutions USA, Inc.
How long has Dr. Marisa A. Kollmeier been practicing?
Dr. Kollmeier graduated from medical school in 1999, 27 years ago.
Does Dr. Marisa A. Kollmeier do research?
Dmand AI links 98 publications to Dr. Kollmeier, published from 2007 to 2024. Dr. Kollmeier has worked on 1 clinical trial.
Who does Dr. Marisa A. Kollmeier publish with?
Dr. Kollmeier's most frequent co-authors are Michael J. Zelefsky, MD (35 shared papers), Daniel J. Gorovets, MD (22 shared papers) and Yoshiya Yamada, MD (18 shared papers).
What insurance does Dr. Marisa A. Kollmeier accept?
Dr. Kollmeier is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.
Selling to radiation oncology practices?
See radiation oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card